Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Increases and Seroprevalence by Type of Clinical Care-September 2021-February 2022.

Kristie E N ClarkeYun KimJefferson JonesAdam LeeYangyang DengElise NyczRonaldo IachanAdi V GundlapalliAdam MacNeilAron Hall

Published in: The Journal of infectious diseases (2022)

Infection-induced seroprevalence more than doubled among children under 12 between September 2021 and February 2022, and increased 85% in adolescents. Differences in seroprevalence by care type did not substantially impact US pediatric seroprevalence estimates.

Keyphrases

sars cov
young adults
healthcare
palliative care
high glucose
diabetic rats
quality improvement
physical activity
drug induced
pain management
oxidative stress
endothelial cells
respiratory syndrome coronavirus
coronavirus disease
chronic pain
childhood cancer
stress induced